Biofil Chemicals & Pharmaceuticals Live BSE/NSE | Biofil Chemicals & Pharmaceuticals Fundamenta data | Biofil Chemicals & Pharmaceuticals Balance sheet | Biofil Chemicals & Pharmaceuticals Quarterly Results | Biofil Chemicals & Pharmaceuticals Profit & Loss | Biofil Chemicals & Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

121.08
87.74
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

122.58
N/A
8.00

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

29.38
31.60
19.81

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
7.13
-17.03

PAT CAGR (%)

10 Years
5 Years
3 Years

-1.17
-4.04
-35.51

P:E (Median)

8 Years
5 Years
3 Years

17.28
18.16
19.45

P:BV (Average)

8 Years
5 Years
3 Years

2.44
2.44
2.44

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.46
12.71
13.67

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 2 2 45% 4 2 50% 13 14 -11% 12 2 443%
Expenses 3 1 89% 3 2 46% 12 14 -10% 11 2 454%
EBITDA 0 0 - 1 0 86% 0 0 -33% 1 0 345%
EBIDTM -13% 14% 14% 11% 2% 3% 8% 9%
Other Income 1 0 6300% 0 0 0% 0 0 350% 0 0 50%
Interest 0 0 -25% 0 0 -25% 0 0 -25% 0 0 -25%
Depreciation 0 0 11% 0 0 -7% 0 0 43% 0 0 43%
PBT 0 0 100% 0 0 186% 0 0 -21% 1 0 618%
Tax 0 0 0 0 0 117% 0 0 0 0 0 0
PAT 0 0 100% 0 0 650% 0 0 -21% 1 0 618%
PATM 9% 7% 4% 1% 2% 2% 7% 5%
EPS 0.13 0.07 86% 0.09 0.01 800% 0.14 0.18 -22% 0.48 0.06 700%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 30 23 12 13 13 6 7 6 6 2 2 Net Sales Growth 48% 87% -8% 2% 125% -18% 19% -4% 192% 22% Cost Of Goods Sold 27 20 10 9 11 4 5 4 5 2 2 Gross Profit 4 3 3 5 3 2 2 2 1 0 0 GP Margin 12% 14% 21% 37% 20% 34% 34% 38% 22% 9% 2% Total Expenditure 29 22 11 11 12 5 6 5 6 3 2 Power & Fuel Cost - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 2% 3% 3% 3% 6% 4% 6% 4% 4% 2% Employee Cost - 1 1 1 0 0 0 0 0 0 0 % Of Sales - 4% 6% 4% 4% 9% 6% 7% 6% 8% 7% Manufacturing Exp. - 0 0 0 0 0 0 0 0 1 0 % Of Sales - 1% 1% 3% 4% 3% 4% 3% 2% 24% 6% General & Admin Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 1% 3% 4% 2% 3% 2% 3% 3% 5% 7% Selling & Distn. Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 2% 0% 2% 0% 0% 4% 0% 0% 0% 0% Miscellaneous Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 1% 0% 1% 1% 1% 1% 19% 21% EBITDA 1 1 1 3 1 1 1 1 0 -1 -1 EBITDA Margin 5% 4% 8% 19% 7% 12% 13% 17% 6% -52% -42% Other Income 1 0 0 0 1 0 0 0 0 2 1 Interest 0 0 0 0 0 0 0 0 0 0 0 Depreciation 0 0 0 0 0 0 0 0 0 0 0 PBT 2 1 1 2 1 1 1 1 0 1 1 Tax 0 0 0 1 0 0 0 0 0 0 0 Tax Rate 16% 20% 20% 23% 20% 20% 20% 19% 6% 0% 0% PAT 1 0 0 2 1 1 1 1 0 1 1 PAT before Minority Interest 1 0 0 2 1 1 1 1 0 1 1 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 5% 2% 4% 13% 6% 10% 7% 9% 2% 46% 31% PAT Growth 162% 2% -74% 129% 32% 13% -4% 260% -85% 83% EPS 0.85 0.29 0.29 1.10 0.48 0.36 0.32 0.33 0.09 0.61 0.33

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Net Sales

Net Sales Growth

48%

87%

-8%

125%

-18%

19%

-4%

192%

22%

Cost Of Goods Sold

Gross Profit

GP Margin

12%

14%

21%

37%

20%

34%

38%

22%

Total Expenditure

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

24%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

19%

21%

EBITDA

-1

EBITDA Margin

19%

12%

13%

17%

-52%

-42%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

16%

20%

23%

20%

19%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

13%

10%

46%

31%

PAT Growth

162%

-74%

129%

32%

13%

-4%

260%

-85%

83%

EPS

0.85

0.29

1.10

0.48

0.36

0.32

0.33

0.09

0.61

0.33

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 14 13 13 11 8 8 7 7 7 2 Share Capital 16 16 16 16 16 16 16 16 16 11 Total Reserves -3 -3 -4 -5 -8 -8 -9 -9 -10 -9 Non-Current Liabilities 0 0 0 0 0 0 0 0 0 4 Secured Loans 0 0 0 0 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 4 Long Term Provisions 0 0 0 0 0 0 0 0 0 0 Current Liabilities 11 11 9 13 5 7 6 7 4 4 Trade Payables 9 9 7 12 2 4 3 5 2 4 Other Current Liabilities 0 0 0 0 0 0 0 0 0 0 Short Term Borrowings 2 2 1 1 3 3 3 2 1 0 Short Term Provisions 0 0 0 0 0 0 0 0 0 0 Total Liabilities 24 24 22 24 14 15 13 14 10 10 Net Block 10 9 9 9 9 9 9 9 8 8 Gross Block 11 10 9 11 11 11 10 10 9 8 Accumulated Depreciation 1 1 0 2 2 2 1 1 1 1 Non Current Assets 10 9 9 9 9 9 9 9 8 8 Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 Non Current Investment 0 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 0 0 0 0 0 0 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 14 15 13 15 5 5 4 5 2 2 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 1 1 0 0 0 0 0 0 0 0 Sundry Debtors 12 13 11 14 4 4 3 4 2 0 Cash & Bank 0 0 0 0 0 0 0 0 0 1 Other Current Assets 1 0 0 0 1 1 1 0 0 1 Short Term Loans & Adv. 0 0 1 1 1 1 1 0 0 1 Net Current Assets 3 4 4 2 -1 -1 -2 -2 -2 -2 Total Assets 24 24 22 24 14 15 13 14 10 10

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Shareholder's Funds

Share Capital

Total Reserves

-3

-4

-5

-8

-9

-10

-9

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-1

-2

Total Assets

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 1 0 1 0 0 0 0 0 -1 3 PBT 1 1 2 1 1 1 1 0 1 1 Adjustment 1 0 0 0 0 0 0 0 0 0 Changes in Working Capital 0 0 -2 -1 -1 -1 -1 -1 -3 2 Cash after chg. in Working capital 1 1 1 0 0 0 0 0 -1 3 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid 0 0 0 0 0 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -1 0 0 0 0 0 0 -1 -1 -1 Net Fixed Assets -1 0 2 0 0 0 0 -1 -1 -1 Net Investments 0 0 0 0 0 0 0 0 0 0 Others 0 0 -2 0 0 0 0 0 0 0 Cash from Financing Activity 0 0 0 0 0 0 0 1 1 -1 Net Cash Inflow / Outflow 0 0 0 0 0 0 0 0 -1 1 Opening Cash & Equivalents 0 0 0 0 0 0 0 0 1 0 Closing Cash & Equivalent 0 0 0 0 0 0 0 0 0 1

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Cash From Operating Activity

-1

PBT

Adjustment

Changes in Working Capital

-2

-1

-3

Cash after chg. in Working capital

-1

Interest Paid

Tax Paid

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-1

Net Fixed Assets

-1

Net Investments

Others

-2

Cash from Financing Activity

-1

Net Cash Inflow / Outflow

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 8 8 8 4 3 3 2 2 2 -2 ROA 2% 2% 8% 4% 4% 4% 4% 1% 10% 6% ROE 4% 4% 18% 13% 13% 14% 16% 5% 463% 0% ROCE 5% 5% 22% 14% 13% 12% 15% 5% 34% 30% Fixed Asset Turnover 2.19 1.28 1.31 1.20 0.54 0.68 0.58 0.64 0.24 0.22 Receivable days 197 361 345 244 241 189 226 163 145 64 Inventory Days 17 18 4 4 14 15 16 8 5 12 Payable days 147 239 318 205 204 204 275 220 413 545 Cash Conversion Cycle 68 139 31 43 51 0 -32 -49 -263 -469 Total Debt/Equity 0.12 0.12 0.11 0.19 0.64 0.70 0.78 0.82 0.45 -1.74 Interest Cover 5 5 15 7 5 5 4 3 110 168

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Book Value (Rs.)

-2

ROA

10%

ROE

18%

13%

14%

16%

463%

ROCE

22%

14%

13%

12%

15%

34%

30%

Fixed Asset Turnover

2.19

1.28

1.31

1.20

0.54

0.68

0.58

0.64

0.24

0.22

Receivable days

197

361

345

244

241

189

226

163

145

Inventory Days

Payable days

147

239

318

205

204

275

220

413

545

Cash Conversion Cycle

139

-32

-49

-263

-469

Total Debt/Equity

0.12

0.11

0.19

0.64

0.70

0.78

0.82

0.45

-1.74

Interest Cover

110

168

Biofil Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524396 | NSE: BIOFILCHEM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Biofil Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524396 | NSE: BIOFILCHEM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update